By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


SEARCH JOBS








Company News
CEL-SCI (CVM) Expands Its Global Phase 3 Immunotherapy Head And Neck Cancer Trial Into Centre Hospitalier Universitaire De Quebec In Canada 8/19/2014 8:52:45 AM
CEL-SCI (CVM) Reports Third Quarter Fiscal 2014 Financial Results 8/11/2014 8:48:09 AM
CEL-SCI (CVM) Reports Third Quarter Fiscal 2014 Financial Results 8/8/2014 3:47:54 PM
CEL-SCI (CVM) Achieves Milestone In July With Total Of 232 Patients Enrolled To Date In Its Phase 3 Head And Neck Cancer Trial 8/1/2014 10:44:38 AM
CEL-SCI (CVM) Has Been Cleared to Begin Patient Enrollment 7/23/2014 12:59:40 PM
CEL-SCI (CVM) Expands Its Phase 3 Head And Neck Cancer Trial Into Sri Lanka 7/17/2014 7:57:45 AM
CEL-SCI (CVM) Receives $225,000 National Institutes of Health (NIH) Research Grant To Develop Rheumatoid Arthritis Treatment 7/15/2014 7:45:53 AM
CEL-SCI (CVM) Receives Regulatory Clearance To Expand CEL-SCI’S Phase 3 Head And Neck Cancer Trial Into Austria 7/8/2014 6:39:05 AM
CEL-SCI (CVM) Reports 93 Percent Increase In Sequential Quarterly Patient Enrollment In Its Phase 3 Head And Neck Cancer Trial 7/1/2014 10:35:53 AM
CEL-SCI (CVM) To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/18/2014 11:30:32 AM
12345678910...
//-->